ProMIS Neurosciences, Inc. (PMN)
10.21
-0.15
(-1.45%)
USD |
NASDAQ |
May 27, 12:48
ProMIS Neurosciences Shareholders Equity (Quarterly) : 60.72M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 567.63M |
| Edesa Biotech, Inc. | 10.20M |
| Xenon Pharmaceuticals, Inc. | 1.338B |
| Medicus Pharma Ltd. | 0.9502M |
| Achieve Life Sciences, Inc. | 10.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 67.41M |
| Total Liabilities (Quarterly) | 6.694M |
| Current Ratio | 9.919 |